Agent for reducing visceral fat
Provide a visceral fat reducing agent for reducing the diseases and conditions associated with the metabolic syndrome which represents a condition where various risk factors such as those for hypertension, hyperlipemia, glucose tolerance dysfunction, etc., have accumulated, or simply reducing an accumulation of visceral fat, wherein the effective ingredient of said visceral fat reducing agent includes fungus bodies of lactic bacteria, especially lactic bacteria belonging to the Lactobacillus sp. and Lactococcus sp. and/or cultures thereof, while also providing a beverage, food or feed containing said visceral fat reducing agent.
1. A method of reducing visceral fat of a subject, comprising:
orally administrating to the subject a composition comprising bacterial cells of lactic acid bacteria belonging to the Lactobacillus sp. and/or Lactococcus sp. and/or cultures thereof in an amount effective to reduce visceral fat of the subject,
wherein the lactic acid bacteria are one or more selected from the group consisting of Lactobacillus gasseri, Lactobacillus helveticus, Lactococcus lactis , and Lactococcus cremoris .
2. The method according to claim 1 , wherein the composition is administrated in an amount of 10 8 to 10 12 cfu per day of the bacterial cells and/or cultures thereof.
3. The method according to claim 1 , wherein the administration of the composition is continued until the ingested bacteria remain stable in the intestinal tracts.
4. The method according to claim 1 , wherein the subject shows a metabolic syndrome prior to the administration of the composition.
5. The method according to claim 1 , wherein the subject is in need of reducing visceral fat.
6. The method according to claim 5 , wherein the composition comprises the bacterial cells of lactic acid bacteria and/or cultures thereof as a main active ingredient.
7. The method according to claim 1 , wherein the lactic acid bacteria are Lactobacillus gasseri .